Published in Hepatitis Weekly, June 21st, 2010
"The aims of this study were to develop a model, which improves the baseline prediction of response to PEG-IFN for individual patients by...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly